Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment Naive”

1,100 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,100 results

Not applicableStudy completedNCT00347217
What this trial is testing

Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event

Who this might be right for
Hypercholesteremia
AstraZeneca 3,840
Early research (Phase 1)Study completedNCT01638650
What this trial is testing

Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 23
Large-scale testing (Phase 3)Study completedNCT01854697
What this trial is testing

Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 311
Testing effectiveness (Phase 2)Study completedNCT01026610
What this trial is testing

Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
LG Life Sciences 115
Testing effectiveness (Phase 2)Study completedNCT00551018
What this trial is testing

Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 218
Testing effectiveness (Phase 2)Study completedNCT00987337
What this trial is testing

Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects

Who this might be right for
HepatitisHepatitis C
Pfizer 288
Testing effectiveness (Phase 2)Study completedNCT02401945
What this trial is testing

A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Santen Inc. 16
Large-scale testing (Phase 3)WithdrawnNCT03814798
What this trial is testing

Study Evaluating IGSC 20% Flexible Dosing in Treatment-Experienced and Treatment-Naive Subjects With Primary Immunodeficiency

Who this might be right for
Primary Immunodeficiency
Grifols Therapeutics LLC
Not applicableLooking for participantsNCT07045688
What this trial is testing

Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection

Who this might be right for
H. Pylori Infection
Sohag University 150
Not applicableLooking for participantsNCT07111273
What this trial is testing

DYNAMIC-UC: Early qFIT and Calprotectin Change Predicting Relapse in Biologic-Naive Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)Fecal CalprotetinFIT+1 more
Qilu Hospital of Shandong University 100
Not applicableStudy completedNCT02471469
What this trial is testing

Personalizing Enzalutamide Therapy by Understanding the Relation Between Tumor mRNAs, miRNAs and Treatment Response

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Radboud University Medical Center 40
Large-scale testing (Phase 3)Study completedNCT03227861
What this trial is testing

Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of Care

Who this might be right for
HIV-1
Janssen Scientific Affairs, LLC 109
Large-scale testing (Phase 3)Study completedNCT01121705
What this trial is testing

Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)

Who this might be right for
Chronic Hepatitis
Casa Sollievo della Sofferenza IRCCS 360
Testing effectiveness (Phase 2)Active Not RecruitingNCT02911142
What this trial is testing

Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma

Who this might be right for
Primary Effusion LymphomaB-Cell Neoplasm
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Ended earlyNCT01313559
What this trial is testing

Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer

Who this might be right for
Castrate Resistant Prostate CancerChemotherapy Naive Prostate CancerProstate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 6
Testing effectiveness (Phase 2)Study completedNCT04382339
What this trial is testing

Sofosbuvir/Pegylated-interferon Plus Ribavirin With HCV Genotype 4

Who this might be right for
Hepatitis C Virus Infection
Beni-Suef University 99
Large-scale testing (Phase 3)Study completedNCT01292239
What this trial is testing

A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 183
Testing effectiveness (Phase 2)Ended earlyNCT04059198
What this trial is testing

Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus

Who this might be right for
Hepatitis BHBVHepatitis B, Chronic
F-star Therapeutics, Inc. 5
Post-approval studies (Phase 4)Study completedNCT00207142
What this trial is testing

Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)

Who this might be right for
HIV Infections
Bristol-Myers Squibb 252
Not applicableActive Not RecruitingNCT07491211
What this trial is testing

Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)Brain Metastases From Non-small Cell Lung Cancer (NSCLC)Osimertinib+1 more
Fudan University 300
Next Page